Skip to main content

Table 3 Comparison of the sputum-culture convention rate in placebo and QBDT group in each site

From: Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen

Sites

Placebo (n = 88)

QBDT (n = 93)

Negative culture

n

Positive culture

n

Withdrawal

n

Negative rate

Negative culture

n

Positive culture

n

Withdrawal

n

Negative rate

1

1

3

2

16.7%

0

1

0

0.0%

2

1

0

0

100.0%

1

0

0

100.0%

3

0

0

0

0.0%

1

1

0

50.0%

4

3

0

0

100.0%

6

1

2

66.7%

5

3

7

2

25.0%

9

3

1

69.2%

6

5

1

0

83.3%

4

0

1

80.0%

7

7

1

0

87.5%

8

0

0

100.0%

8

4

3

1

50.0%

2

1

3

33.3%

9

9

0

1

90.0%

11

0

0

100.0%

10

15

3

0

83.3%

17

0

2

89.5%

11

11

1

0

91.7%

13

0

1

92.9%

12

2

1

1

50.0%

2

1

1

50.0%

Total

61

20

7

69.3%

74

8

11

79.6%

  1. QBDT Qinbudan tablet; Covariance analysis was used to correct the rate differences of primary endpoints. The covariate variable sites as follows: 1 Shanghai pulmonary hospital affiliated Tongji University, 2 Beijing chest hospital affiliated Capital medical university, 3 the first affiliated hospital of Chongqing medical university, 4 Shenzhen Donghu hospital, 5 Hebei provincial chest hospital, 6 Jiangxi provincial chest hospital, 7 Tianjin Haihe hospital, 8 Shenyang chest hospital, 9 Wuhan tuberculosis dispensaries, 10 the first affiliated hospital of Xinxiang Medical University, 11 Uygur Autonomous Region of Xinjiang Chest Hospital, 12 the 85th hospital of Chinese people’s liberation army